Most explanations of collagen and perimenopause treat it as a slow fade: a fixed percentage lost per year, evenly spread across a decade or more. That's not what the research shows. Menopause collagen loss behaves less like erosion and more like a threshold being crossed, gradual in the years leading up to it, then abrupt once estrogen drops sharply.
We call this the menopause collagen cliff, and it isn't a metaphor. It's what happens when a single hormonal signal that coordinates collagen production across the whole body goes quiet all at once.
Understanding that mechanism, rather than treating collagen loss as a vague consequence of "getting older," is the difference between chasing symptoms individually as they show up and recognizing them as one connected event with one identifiable cause.
The Mechanism Behind Collagen Loss in Menopause
Estrogen receptors sit directly on fibroblasts, the cells that build skin’s structural collagen, as well as on the bone-building cells and connective tissue cells found throughout the body.¹ Estrogen doesn’t just support these cells passively. It actively signals them to increase collagen production while suppressing matrix metalloproteinases (MMPs), the enzymes responsible for breaking existing collagen down.² This is a two-part system: more building on one side, less breaking down on the other, kept in balance for as long as estrogen levels stay relatively stable.
Menopause disrupts both sides of that system at once. As estrogen drops sharply, fibroblasts and related cells produce less new collagen, while MMP activity increases and accelerates the breakdown of what’s already there. The result isn’t a slow, even decline. It’s a compounding deficit, less being built, more being lost, happening simultaneously.
Why the Decline After Menopause Feels Like a Collagen Cliff
This mechanism explains something many of us notice but rarely have language for: skin, joints, and bone that seem to change quickly, almost overnight, rather than gradually over many years. Research tracking skin collagen directly has found that women lose close to 30% of their skin collagen in the first five years after menopause alone, with continued yearly losses after that.³ That pace is dramatically faster than the slower, steadier decline associated with ordinary aging before perimenopause.
Menopause Collagen Loss Isn’t Limited to Skin
Because estrogen receptors exist on collagen-building cells throughout the body, menopause collagen loss shows up in bone and connective tissue at the same time it’s showing up in skin, not as a separate, unrelated process. A 12-month randomized controlled trial of postmenopausal women found that a placebo group continued to lose bone mineral density (BMD) over the study period, while women receiving daily specific collagen peptides saw measurable gains at the spine and hip.⁴ This parallel timing, skin, bone, and joint changes clustering together, is one of the clearest signs that a single hormonal shift, not several unrelated ones, is driving the whole picture.
What Collagen Loss in Menopause Really Means
Collagen loss in menopause isn't a vague symptom of time passing. It's a specific hormonal mechanism, which means it responds to specific inputs, not just to time or general wellness habits.
The estrogen signal that once coordinated collagen maintenance can't simply be restored through diet or skincare alone, but the structural collagen-building cells across skin, bone, joint, and connective tissue are still there, and still responsive to other evidence-based inputs.
This is where bioactive collagen peptides come in: specific, clinically studied peptide fragments shown to signal fibroblasts and other collagen-building cells directly, working through a pathway that doesn’t depend on estrogen to function. Clinical research on these peptides has found measurable gains in skin elasticity within 8 weeks and bone mineral density within 12 months, evidence that the underlying cells can still be prompted to build, even after the hormonal signal that once coordinated them has weakened.
That’s the foundation of how Monna approaches structural aging: not as an inevitable, unmanageable decline, but as a specific mechanism that can be understood and supported.